Skip to main content

Bronchoscopy

2
Pipeline Programs
6
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Paion
PaionGermany - Aachen
1 program
1
RemimazolamPhase 31 trial
Active Trials
NCT02296892Completed446Est. Mar 2017
Pulmonx
PulmonxCA - Redwood City
1 program
1
Chartis SystemPhase 11 trial
Active Trials
NCT00684684Completed18Est. Nov 2008
Ambu
AmbuDenmark - Ballerup
2 programs
Clinical Validation Trial of a Single-use Bronchoscope (Ambu® aScope ™ 4)N/A1 trial
aScope 4 BronchoN/A1 trial
Active Trials
NCT03419546Completed216Est. Aug 2018
NCT03294213Completed176Est. Jan 2018
Eisai
EisaiChina - Liaoning
1 program
AQUAVAN®PHASE_31 trial
Active Trials
NCT00306722Completed250Est. May 2007

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PaionRemimazolam
EisaiAQUAVAN®
PulmonxChartis System
AmbuClinical Validation Trial of a Single-use Bronchoscope (Ambu® aScope ™ 4)
AmbuaScope 4 Broncho

Clinical Trials (5)

Total enrollment: 1,106 patients across 5 trials

NCT02296892PaionRemimazolam

A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy

Start: Apr 2015Est. completion: Mar 2017446 patients
Phase 3Completed
NCT00306722EisaiAQUAVAN®

An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible Bronchoscopy

Start: Apr 2006Est. completion: May 2007250 patients
Phase 3Completed
NCT00684684PulmonxChartis System

Safety and Feasibility Study of the Chartis System

Start: May 2008Est. completion: Nov 200818 patients
Phase 1Completed
NCT03419546AmbuClinical Validation Trial of a Single-use Bronchoscope (Ambu® aScope ™ 4)

Clinical Validation Trial of a Single-use Bronchoscope (Ambu® aScope ™ 4)

Start: Mar 2018Est. completion: Aug 2018216 patients
N/ACompleted
NCT03294213AmbuaScope 4 Broncho

Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aView

Start: Sep 2017Est. completion: Jan 2018176 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.